>do you know of any fundamental reason for the recent IDIX decline other than the obvious deplorable market conditions?<
No, I do not. As mentioned in #msg-32659390, through Friday IDIX was the eighth-best performing stock this year in the entire Russell 3000 index. Hence, it may have been overripe for a correction during a broad-market selloff.
I just listened to today’s IDIX presentation at the JMP conference—nothing new.
IDIX – Actually, there is one new minor piece of news: the first paper on IDX375, IDIX’s non-nucleoside HCV polymerase inhibitor, will be presented at AASLD next month.
Market Data 
Markets 
AI
